Buy Semaglutide OXY-SEMA (10 mg) Oxypharma in Ukraine Semaglutide is an analogue of glucagon-like peptide 1 (GLP-1), with 94% sequence identity to human GLP-1. It acts as a GLP-1 receptor agonist, binding selectively and activating the GLP-1 receptor. Semaglutide reduces blood glucose in a glucose-dependent manner — stimulating insulin secretion and lowering glucagon secretion when blood glucose runs high. The glucose-lowering mechanism also involves a slight slowing of gastric emptying. During hypoglycaemia, semaglutide reduces insulin secretion and does not interfere with glucagon secretion. Semaglutide trims body weight and body fat mass through a general drop in appetite. Buy Semaglutide 10 mg online — indications for use • Adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus • To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease Semaglutide 10 mg Dosage The starting dose of Semaglutide is 0.25 mg semaglutide once a week. After 4 weeks, the dose should be raised to 0.5 mg once weekly. After at least 4 weeks at 0.5 mg weekly, the dose may be lifted to 1 mg once weekly for further glycaemic improvement. Weekly doses above 1 mg are not recommended. Semaglutide is given once a week at any time of day, with or without food. It is injected subcutaneously into the abdomen, thigh or upper arm. The injection site can be rotated without adjusting the dose. Semaglutide should not be administered intravenously or intramuscularly. If needed, the day of weekly dosing can be shifted provided the interval between two doses is at least 3 days (>72 hours). After picking a new day, the drug should still be taken once a week. Precautions Diabetic ketoacidosis: semaglutide should not be used in type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Pancreatitis: if pancreatitis is suspected, semaglutide should be discontinued immediately — if confirmed, do not restart. Diabetic retinopathy: patients with diabetic retinopathy should be monitored. Use during pregnancy and lactation Semaglutide should not be used during pregnancy. Patients planning a pregnancy should stop semaglutide at least 2 months beforehand. Risk to a breastfed baby cannot be ruled out, so semaglutide should not be used while breast-feeding. Interaction with other drugs Semaglutide slows gastric emptying and may affect the absorption rate of oral drugs taken alongside it. Caution is advised in patients taking oral medications that need rapid gastrointestinal absorption. Overdose Clinical studies have reported overdoses of up to 4 mg at a time and up to 4 mg per week. The most common adverse reaction was nausea. There is no specific antidote for semaglutide overdose. In case of overdose, supportive treatment should be initiated according to the patient’s clinical signs and symptoms. Storage Store between 2 °C and 8 °C (in the refrigerator). Do not freeze. Keep out of the reach of children. Semaglutide 6 mg is available online in Ukraine, Kyiv and other cities with cash on delivery. ECA fat burners, clenbuterol, T3, Semaglutide OXY-SEMA (10 mg) Oxypharma
Semaglutide OXY-SEMA (10 mg) OxyPharma
€0.00
Semaglutide OXY-SEMA (10 mg) OxyPharma — product information
Semaglutide is an analogue of glucagon-like peptide 1 (GLP-1), with 94% sequence identity to human GLP-1. It acts as a GLP-1 receptor agonist, binding selectively to the GLP-1 receptor and activating it. Blood glucose is lowered in a glucose-dependent manner — insulin secretion is stimulated and glucagon secretion is reduced when blood glucose runs high. A mild delay in gastric emptying contributes to the glucose-lowering effect too. During hypoglycaemia, semaglutide dials back insulin secretion while leaving glucagon secretion alone. Body weight and body fat mass come down through a general reduction in appetite.
Semaglutide 10 mg — indications for use
• Adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus
• Reduction of risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease
Semaglutide 10 mg — dosage
Semaglutide starts at 0.25 mg once weekly. After 4 weeks the dose is raised to 0.5 mg once a week. After at least 4 weeks on the 0.5 mg once-weekly dose, further increase to 1 mg once weekly is permitted when additional glycaemic control is needed. Weekly doses above 1 mg are not recommended.
Dosing is once a week at any time of day, with or without food. The injection goes subcutaneously into the abdomen, thigh or upper arm. The site can be rotated without any dose adjustment. Semaglutide should not be administered intravenously or intramuscularly. The day of weekly dosing may be shifted when needed — provided at least 3 days (>72 hours) sit between two doses. Once a new day is picked, weekly dosing continues from there.
Precautions
Diabetic ketoacidosis. Semaglutide should not be used in type 1 diabetes mellitus, nor for the treatment of diabetic ketoacidosis.
Pancreatitis. If pancreatitis is suspected, semaglutide should be stopped immediately. If pancreatitis is confirmed, do not restart.
Diabetic retinopathy. Patients with diabetic retinopathy should be monitored.
Use during pregnancy and lactation
Semaglutide shouldn’t be used during pregnancy. If a patient wishes to become pregnant, semaglutide should be discontinued at least 2 months before the planned pregnancy. Since risk to a breastfed child can’t be excluded, semaglutide shouldn’t be used during breastfeeding either.
Interaction with other drugs
Semaglutide slows gastric emptying and may affect the absorption rate of concurrently taken oral drugs. Caution is called for in patients on oral medications that require rapid gastrointestinal absorption.
Overdose
Clinical studies have reported overdoses of up to 4 mg at a single administration and up to 4 mg per week. Nausea was the most commonly reported reaction. No specific antidote for semaglutide overdose exists. Supportive treatment is initiated according to the patient’s clinical presentation.
Storage
Store at temperatures between 2 C and 8 C (in the refrigerator). Do not freeze. Keep out of reach of children.
ECA fat burners, clenbuterol, T3, Semaglutide OXY-SEMA (10 mg) Oxypharma
Out of stock
Semaglutide, a GLP-1 receptor agonist, slows gastric emptying and dampens appetite signalling via central and peripheral pathways. The 10 mg vial covers an extended titration-to-maintenance run — typically 0.25 mg weekly for the first month, stepping up every four weeks toward a 2.4 mg maintenance for weight management. Reconstitute with 1–2 ml bacteriostatic water, pulling 20 or 40 doses from a single vial. Keep refrigerated throughout, and rotate injection sites to minimise local reactions. Early nausea tends to fade within a fortnight at each step.
| Peptide | Semaglutide |
| Vial content | 10 mg lyophilised |
| Producer | OxyPharma |
| Receptor target | GLP-1 receptor agonist |
| Weekly dose | 0.25 mg titrated gradually to 2.4 mg |
| Reconstitution | Bacteriostatic water, usually 2–3 ml |
| Route | Subcutaneous |
| Storage | Refrigerated at 2–8 °C |
Semaglutide at 10 mg per vial — a long-run supply for anyone past the first few months of GLP-1 titration.
By this stage, weekly doses usually sit at 1.0–2.4 mg, reached through the standard four-week step pattern. The peptide lowers appetite via central GLP-1 pathways and slows gastric emptying. Side effects — nausea, early satiety, occasional reflux — tend to settle after the first weeks. Monthly weigh-ins keep progress on track.
Frequently Asked Questions
How is a 10 mg Semaglutide vial dosed?
A 10 mg vial covers several weeks once reconstituted, with weekly doses climbing from 0.25 mg to 2.4 mg. Each dose is drawn with an insulin syringe.
Can Semaglutide be used alongside strength training?
Semaglutide is a GLP-1 receptor agonist. Weekly injections are titrated upward every few weeks until the weight-loss goal is reached.
What is the typical titration schedule for Semaglutide?
The protocol starts low — starts at 0.25 mg weekly, titrated up to 2.4 mg — and keeps going for several months of weekly dosing.
What happens if a weekly dose of Semaglutide is missed?
A 10 mg vial covers several weeks of weekly dosing once past the entry phase. Users titrate up from 0.25 mg to avoid nausea.
How is the Semaglutide dose titrated upward?
Users typically start at 0.25 mg weekly and double the dose every four weeks until reaching the target or hitting a tolerable ceiling.
Reviews
There are no reviews yet